Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation

导出原文传递

翻译打印收藏纠错

作者： Shi, Zhengzheng ^[1] ; Zhou, Qing ^[2] ; Gao, Shuhong ^[3] ; Li, Wenzhi ^[4] ; Li, Xin ; Liu, Zhiming ; Jin, Pengpeng ; Jiang, Jie

作者单位： Binzhou Med Univ, Affiliated Hosp, Dept Obstet & Gynecol, Binzhou 256603, Shandong, Peoples R China ^[1] Fudan Univ, Pudong Med Ctr, Shanghai Pudong Hosp, Ctr Med Res & Innovat, Shanghai 201399, Peoples R ^[2] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, 107 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples ^[3] Zaozhuang Municipal Hosp, Dept Gynecol, Zaozhuang 277000, Shandong, Peoples R China ^[4]

关键词 Silibinin Endometrial carcinoma STAT3 SREBP1 Proliferation Apoptosis Lipid metabolism

发布时间 2019-11-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Life sciences

2019年217卷

70-80页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation

Life sciences

相似文献

Life sciences

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation

Life sciences

相似文献

Life sciences

相关期刊

检索历史清除